# Vor Biopharma Inc.: Form SCHEDULE 13D/A, filed Jul 21, 2026

- Company: [Vor Biopharma Inc.](/companies/vor.md) (CIK 1817229)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-21
- Accepted by EDGAR: Jul 21, 2026, 16:55 ET
- Period: not reported
- Accession: 0001346824-26-000197
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817229/000134682426000197/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817229/000134682426000197/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817229/000134682426000197/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000197. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.